Publications by authors named "David N Standring"

Claim this Profile
E
Evaluation of the role of three candidate human kinases in the conversion of the hepatitis C virus inhibitor 2'-C-methyl-cytidine to its 5'-monophosphate metabolite.
Nina L Golitsina, Francis T Danehy, Ross Fellows, Erika Cretton-Scott, David N Standring

Antiviral Res· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Telbivudine, a nucleoside analog inhibitor of HBV polymerase, has a different in vitro cross-resistance profile than the nucleotide analog inhibitors adefovir and tenofovir.
Maria Seifer, April Patty, Ilaria Serra, Bin Li, David N Standring

Antiviral Res· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and pharmacokinetics of valopicitabine (NM283), an efficient prodrug of the potent anti-HCV agent 2'-C-methylcytidine.
Claire Pierra, Agnès Amador, Samira Benzaria, Erika Cretton-Scott, Marc D'Amours, David N Standring

J Med Chem· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis